You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
3 September 2021
Futura Medical has announced a collaboration to commercialise its topical erectile-dysfunction product MED3000 in Brazil and Mexico.
3 May 2021
Futura Medical’s MED3000 topical gel for erectile dysfunction has now been certified as a Class IIb medical device in the European Union. The company told OTCToolbox it was "in discussions with a number of parties" about marketing and distribution rights.
15 April 2021
Futura Medical has reported its annual results, and Alliance Pharma is losing a non-executive director.
25 March 2021
Futura Medical’s MED3000 medical device for erectile-dysfunction has moved a step closer to a launch in the European Union.
4 March 2021
Bayer has signed a distribution deal in Egypt, Futura Medical has announced a collaboration in China and South-East Asia, Ipsen has released financial results, and the US Consumer Healthcare Products Association (CHPA) has three new member companies.